Cystic Fibrosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018–2024

Report Code: ZMR-2895 | Report Format : | Status : Upcoming |

Abstract

Cystic Fibrosis Therapeutics Market: Overview

Cystic fibrosis is an autosomal recessive and monogenetic disorder as a result of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is a protein (transmembrane) that transports ions across the surface of epithelial cells. CFTR dysfunction affects a number of organs but lung disease is responsible for the majority of mortality in patients with cystic fibrosis.

CF is an autosomal recessive disease as a result of mutations in a gene located on chromosome 7. The CFTR is a single polypeptide protein containing 1480 amino acids that are observed to function both as a cyclic AMP-regulated, Cl- channel and as a regulator of other ion channels. The fully organized form of CFTR is found in the plasma membrane in normal epithelia. In a normal functioning cell, CFTR is synthesized in the rough endoplasmic reticulum (RER) followed by glycosylation in the Golgi apparatus and performing the function of a Cl- channel, and regulator of other ion channels when located in the plasma membrane. However, there can be two possible mutations in the CFTR gene, viz., (1) If a mutation disturbs protein folding, CFTR is degraded intracellularly thus, no protein is transported to the plasma membrane. (2) With other mutations, the abnormal protein is processed, reaches to the plasma membrane but functions abnormally at that site.

Cystic Fibrosis Therapeutics Market: Market Dynamics

The rising prevalence of Cystic Fibrosis (CF) globally, improved diagnostic technologies, growing investment in and awareness about genetic diseases, favorable initiatives undertaken by nonprofit organizations, development of the Healthcare industry and research and development activities undertaken by key players are expected to boost the market over the forecast period.

The market restraints include Cystic Fibrosis Related Complications, Increased Risk of Bacterial Infections in Cystic Fibrosis Patients, high cost involved in treatment and increase in complexity of the disease. Observed new opportunities in Cystic Fibrosis Therapeutic market include patent expiry of many innovator drug companies for Cystic Fibrosis leading to the introduction of generic drugs, Gene Therapy breakthrough for Cystic Fibrosis, a better understanding of the genetic structure which would help in innovating new drugs/therapies.

Segmentation based on Cystic Fibrosis therapeutic drug class:

Based on the therapeutic drug class the segmentation is Mucolytics, CFTR modulators, Pancreatic enzyme supplements and Bronchodilators.

Segmentation based on Cystic Fibrosis therapeutic route of administration:

Based on the route of drug administration, Oral drugs, and Inhaled drugs.

Segmentation based on regions:

North America leads the market for F.Y. 2016; as CF is most prevalent in North America due to the fact that most of the people affected with CF are of Caucasian descent, initiatives taken by Cystic Fibrosis Canada and CF Foundation are one of the key reasons that can be accounted for its largest share. Europe has the second-largest revenue share in global cystic fibrosis therapeutics, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. It is a rapidly growing segment in Asia-Pacific due to raising awareness about CF disorders & various treatment options. In addition, economic development in this region and improving healthcare facilities drive the market in this region.

Cystic Fibrosis Therapeutics Market: Competitors

Key manufacturers of Cystic Fibrosis Therapeutics include Hoffmann-La Roche Ltd, Gilead Sciences Inc, Merck & Co Inc, AbbVie Inc, Allergan plc, Alcresta Therapeutics Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, AstraZeneca Plc. among others

Cystic Fibrosis Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Rheumatoid Arthritis Drugs Market by Drug Type (NSAID’s, Analgesics, DMARD’s, Glucocorticoids, Biologics, and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Apr-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3999 | Report Format:

The report covers a forecast and an analysis of the rheumatoid arthritis drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the rheuma...Read More

Pharmaceutical Vials Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3985 | Report Format:

Global Pharmaceutical Vials Market: Overview Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients i...Read More

Immuno Oncology Assays Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3963 | Report Format:

Global Immuno Oncology Assays Market: Overview Immuno Oncology Assays are used when testing immunotherapies as it is often critical to assess thefunctional cytotoxicity and infiltration capacity. In addition, Immunomodulators effects of these new drugs in combination with already approved ones n...Read More

Drug Integrated Polymer Fibers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3933 | Report Format:

Global Drug Integrated Polymer Fibers Market: Overview Drug integrated polymers fibers are generally made from biodegradable and biocompatible materials such as poly lactic acid and its derivatives such as PLLA, polydioxanone, polycaprolactone, polyglycolic acid, poly(lactic-co-glycolic acid), a...Read More

Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3926 | Report Format:

The report covers a forecast and an analysis of the gynecological drugs market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gyneco...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.